Observational studyDiabetic medicine : a journal of the British Diabetic Association2026
Relationship between patient activation, experienced stigma, and internalised weight stigma in people with type 2 diabetes.
Observational study in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Relationship between patient activation, experienced stigma, and internalised weight stigma in people with type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimsPatient activation is associated with disease self-management; limited research has examined the role of perceived stigmatisation in this relationship. We explored links between diabetes and weight stigma, internalised weight stigma, and patient activation among people with type 2 diabetes (T2D).
methodsThis observational, survey-based study was conducted among 857 US adults with T2D. Mean scores were reported for participant-reported outcome (PRO) measures, including first use in research of the Influence and Motivation for Patient Activation in Diabetes Care Measure (IMPACT-D™), Weight Self-Stigma Questionnaire (WSSQ), Type 2 Diabetes Stigma Assessment Scale (DSAS-2), Diabetes Self-Management Questionnaire (DSMQ), Brief Illness Perception Questionnaire (Brief-IPQ), and questions about perceived weight stigma and discrimination. Additional subgroup analyses were based on total PRO scores.
resultsParticipants with lower degrees of activation (lower IMPACT-D™ scores) experienced greater self-stigma (WSSQ scores) compared with those with higher degrees of activation. People with high weight-related self-stigma (WSSQ scores) experienced more self-stigma (high Brief-IPQ, DSAS-2 scores), lower activation, and poorer glycaemic self-management (lower IMPACT-D™, DSMQ scores) than people with less self-stigma. Higher degrees of self-stigma (high WSSQ and DSAS-2 scores) were reported among people who faced weight-related stigma compared with those who did not.
conclusionGreater degrees of self-stigma were associated with lower degrees of participant activation and poorer glycaemic self-management. The exploratory findings indicate the need for increased efforts to reduce stigma, identify, and provide appropriate support and encouragement to participants with lower activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.